Log in or Sign up for Free to view tailored content for your specialty!
Stroke/Vascular Neurology News
Low-dose tenecteplase safe, effective up to 24 hours after ischemic stroke onset
Administration of low-dose IV tenecteplase in the 4.5 to 24 hours after stroke symptom onset seemed to be safe and effective in the reperfusion and recanalization of occluded large cerebral vessels, a speaker reported.
White matter hyperintensities 1 year after stroke linked to cognitive scores
White matter hyperintensity volumes at 1 year strongly correlated with contemporaneous cognitive scores after stroke, according to study results published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
DOACs safer than warfarin in patients with cerebral venous thrombosis
In patients with cerebral venous thrombosis, direct oral anticoagulants were safer than warfarin without compromising efficacy, researchers reported at the International Stroke Conference.
Intensive dental treatment after stroke, TIA does not impact vascular events
Intensive periodontal treatment for gum disease after stroke or transient ischemic attack did not affect the rate of vascular events at 1 year compared with standard treatment, a speaker reported.
Mobile units provide faster care, better outcomes in acute ischemic stroke
Compared with standard care, use of mobile units sharply increased the odds of positive outcomes and reduced treatment times for acute ischemic stroke, according to a systematic review and meta-analysis published in JAMA Neurology.
Tirofiban fails to improve stroke outcomes when added to EVT, but questions remain
In patients with acute ischemic stroke with large vessel occlusion who underwent endovascular therapy, tirofiban did not improve outcomes and raised risk for intracerebral hemorrhage, researchers reported.
EVT improves outcomes in large vessel occlusion with large cerebral infarction
Endovascular therapy for patients with acute large vessel occlusion with large ischemic core improved their likelihood of achieving a favorable outcome at 90 days by more than twofold vs. medical therapy alone, a speaker reported.
Anger, emotional upset associated with stroke
Anger or emotional upset was associated with all stroke types, according to study findings published in European Heart Journal.
Delayed treatment with cilostazol key to preventing stroke recurrence
Commencing long-term dual antiplatelet therapy with cilostazol no less than 15 days after stroke proved to be a stronger method of secondary stroke prevention than standard monotherapy, according to study results published in Neurology.
Serum glucose may help identify those admitted for stroke at greatest risk for recurrence
Presence of hyperglycemia at hospital admission for stroke was linked with elevated risk for subsequent stroke by 90 days, an increase that dual antiplatelet therapy seemingly failed to curtail, researchers reported.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read